CopyCat

What do they actually do

CopyCat builds an AI system for dermatology clinics that automates biopsy callbacks and other routine patient outreach. It connects to dermatology EHRs (they highlight EMA and EzDerm), identifies patients who need follow‑up after pathology, and contacts them via phone, text, or email to explain results in plain language, answer common questions, and, when needed, book treatment based on the clinic’s scheduling rules. Clinics can run messages automatically or require staff approval first, and outcomes are logged back into clinic workflows/EHRs (CopyCat homepage, FAQ/Contact, YC profile).

Beyond callbacks, the company positions a broader dermatology workflow product with features like scheduling assistance, insurance verification, HPI summarization, single‑photo documentation, and proactive fax triage. They emphasize HIPAA compliance and “white‑glove” onboarding. The site does not publish independent customer counts or audited outcomes; improvement claims are marketing statements on their pages (CopyCat homepage, FAQ/Contact).

CopyCat has also described a general “browser‑agent” automation product for web workflows, which appears to be a parallel capability or enabling tech for integrations outside standard APIs (YC Launch).

Who are their target customer(s)

• Solo dermatologist / small private practice owner: Clinician and front‑desk time is spent calling patients about pathology results and explaining benign vs. concerning findings, pulling staff away from billable work; they want callbacks handled reliably inside their dermatology EHR (homepage, FAQ).
• Clinic operations manager at a multi‑provider practice: Manual callbacks, rebooking, and tracking follow‑ups create scheduling gaps and extra admin headcount; they need automated outreach with approval queues and clean EHR logging (FAQ, homepage).
• Medical director or clinical lead for quality/safety: Missed or delayed follow‑ups after pathology and inconsistent patient messaging risk poor outcomes and complaints; they want standardized biopsy callbacks and audit‑friendly records (YC profile, FAQ).
• Billing/scheduling staff and front desk: Large time sink from phone calls and repeated questions about results; manual scheduling updates lead to errors and burnout. They need automated calls/texts and two‑way scheduling syncs with staff review options (homepage, FAQ).
• IT/compliance lead at a practice or health system: Vendors must integrate securely with dermatology EHRs, meet HIPAA/audit requirements, and avoid heavy site‑by‑site setup. They want proven EMA/EzDerm integrations and standardized onboarding (FAQ, homepage).

How would they acquire their first 10, 50, and 100 customers

• First 10: Founder‑led, short pilots with on‑site observation and hands‑on setup for local solo/small practices to prove biopsy‑callback ROI and harden EMA/EzDerm integrations (homepage, FAQ).
• First 50: Codify a remote‑first onboarding playbook, use referrals/case studies from early pilots, and add targeted outbound to multi‑provider groups; proactively address approval queues, EHR logging, and HIPAA in sales (FAQ, homepage).
• First 100: Develop channel partnerships with EHR vendors/resellers (starting with EMA/EzDerm), launch a self‑serve tier, and standardize templates/training for remote onboarding; invest in BAA/SOC2 artifacts to shorten enterprise cycles (FAQ, YC profile).

What is the rough total addressable market

Top-down context:

There are roughly 12,120 practicing dermatologists in the U.S. as of 2023, per AAD‑linked analyses, mostly concentrated in outpatient clinic settings (JAAD 2024).

Bottom-up calculation:

If average clinics have ~3 dermatologists, that implies ~4,000 U.S. dermatology practices. At an estimated $12,000/year per clinic for biopsy callbacks and related automations, U.S. TAM ≈ $48M; adding broader workflow modules or international clinics would expand this.

Assumptions:

• Average of ~3 dermatologists per practice (mix of solo and multi‑provider groups).
• Pricing modeled as ~$1,000/month per clinic for outreach + workflow automations; excludes larger enterprise tiers.
• Initial focus is U.S. outpatient dermatology practices, not hospital‑owned departments.

Who are some of their notable competitors

• Solutionreach: General patient engagement platform (reminders, recalls, two‑way texting, EHR syncs). Overlaps on replacing manual outreach/scheduling but is not biopsy‑specific or dermatology‑native (Solutionreach, Integrations).
• Luma Health: EHR‑integrated outreach and scheduling for specialties, including dermatology; competes on specialty workflows and care‑gap campaigns that can include biopsy follow‑ups (Luma, Dermatology).
• Klara: Secure two‑way messaging and workflow automation used by specialty practices; competes on message‑first callbacks and triage rather than autonomous voice explanations of pathology (Klara, Customer story).
• WELL Health: Enterprise omni‑channel patient communications (SMS, IVR/voice, email) with major EHR partnerships; strong in health systems and multi‑site groups (Twilio case, MEDITECH partnership).
• Notable Health: AI + RPA platform with agents that read/write the EHR and run voice/SMS outreach; closest to CopyCat’s automation approach and two‑way scheduling depth (Notable overview, Integrations/use cases).